Brief: Odonate Therapeutics Q3 Loss Per Share $0.88

Odonate

06/11/2019 13:51

Nov 6 (Reuters) - Odonate Therapeutics Inc  ODT.O :
    * ODONATE THERAPEUTICS ANNOUNCES FINANCIAL RESULTS FOR THE
THREE
AND NINE MONTHS ENDED SEPTEMBER 30, 2019
    * Q3 LOSS PER SHARE $0.88
    * AS OF SEPTEMBER 30, 2019, ODONATE HAD $204.2 MILLION IN
CASH,
COMPARED TO $139.1 MILLION AS OF DECEMBER 31, 2018
    * EXPECT TO REPORT TOP-LINE RESULTS FROM CONTESSA IN Q3 OF
2020

Source text for Eikon:  ID:nBw8xgwS2a 
Further company coverage:  ODT.O 

 ((Briefs@thomsonreuters.com;))